The Thoracic Surgical Oncology Clinical Trial Research Training Fellowship provides thoracic surgeons with in-depth, hands-on clinical trial research training at an industry partner, led by the American Association for Thoracic Surgery.
Funder: American Association for Thoracic Surgery
Due Dates (Anticipated): July 2027 (Full application deadline, projected)
Funding Amounts: $100,000 for a 12-month onsite fellowship at an industry partner facility (typically AstraZeneca)
Summary: Immersive clinical trial research training for thoracic surgeons, focusing on trial design and data analysis in partnership with leading industry facilities.
Key Information: This is a forecasted opportunity; exact dates and requirements may vary in future cycles.
The Thoracic Surgical Oncology Clinical Trial Research Training Fellowship is designed to provide thoracic surgeons with rigorous, hands-on training in the design and execution of clinical trials within an industry-academic environment. Fellows spend 9–12 months onsite at a pharmaceutical industry partner—typically AstraZeneca—gaining direct experience in clinical trial design, protocol writing, endpoint selection, and data interpretation. The program aims to deepen fellows’ understanding of late-stage clinical development, expose them to emerging therapies, and foster the skills needed to lead and contribute to multidisciplinary cancer research. Fellows are expected to complete a clinical research project, contribute to scientific publications, and present their work at relevant conferences.